Literature DB >> 19822402

Clustered subclinical seizures in a patient with acute encephalopathy with biphasic seizures and late reduced diffusion.

Mitsutaka Komatsu1, Akihisa Okumura, Kotoko Matsui, Tomohiro Kitamura, Toshihiko Sato, Toshiaki Shimizu, Kazuyoshi Watanabe.   

Abstract

Using single-channel amplitude-integrated electroencephalography (aEEG), we monitored clustered seizures in a 12-month-old boy suffering from acute encephalopathy with biphasic seizures and late reduced diffusion (AESD). He was admitted to our hospital after losing consciousness and experiencing repeated seizures in association with fever. Although the patient's state of consciousness improved the next day, it declined on the fifth day of illness, and clinical seizures were observed. Diffusion-weighted images revealed abnormal high intensities in the frontal area bilaterally. On the same day, aEEG monitoring revealed an unexpected cluster of subclinical seizures. Attending pediatricians, nurses, and other caregivers did not recognize the presence of these frequent subclinical seizures. The efficacy of antiepileptic drugs could also be objectively assessed from aEEG findings. aEEG is useful for continuous monitoring in children with acute encephalopathy, may disclose subclinical seizures, and can contribute to an objective evaluation of the efficacy of antiepileptic drugs. Copyright (c) 2009 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2009        PMID: 19822402     DOI: 10.1016/j.braindev.2009.09.012

Source DB:  PubMed          Journal:  Brain Dev        ISSN: 0387-7604            Impact factor:   1.961


  1 in total

1.  Distinguishing Acute Encephalopathy with Biphasic Seizures and Late Reduced Diffusion from Prolonged Febrile Seizures by Acute Phase EEG Spectrum Analysis.

Authors:  Masayoshi Oguri; Yoshiaki Saito; Chisako Fukuda; Kazuko Kishi; Atsushi Yokoyama; Sooyoung Lee; Hiroyuki Torisu; Mitsuo Toyoshima; Hitoshi Sejima; Shunsaku Kaji; Shin-Ichiro Hamano; Toru Okanishi; Yutaka Tomita; Yoshihiro Maegaki
Journal:  Yonago Acta Med       Date:  2016-04-01       Impact factor: 1.641

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.